Delicious
Digg
Facebook
LinkedIn
Twitter
Investors
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. Our strategy is to commercialize our products in the U.S. and to enter into licensing or additional distribution agreements for commercialization of our products outside the U.S.. As part of our longer-term strategy, we anticipate we will selectively co-promote, in-license or acquire additional products and/or late stage product candidates that are synergistic with our commercial strategy.
Horizon Pharma has partnered with the following companies:
- Mallinckrodt LLC - U.S. DUEXIS Co-Promotion Agreement
- Mundipharma International - EU, Asia and Latin America LODOTRA Distribution and Supply Agreements
- Grunenthal S.A. – Latin America DUEXIS Collaboration License & Supply Agreement
If you would like to discuss partnership opportunities with Horizon Pharma please contact:
Joe Whalen
Vice President, Business Development and Alliance Management
Horizon Pharma, Inc.
520 Lake Cook Road, Suite 520
Deerfield, IL 60015
bd@horizonpharma.com
View all 
Recent Releases
Horizon Pharma Announces First Quarter 2013 Financial Results and Provides Business Update
DEERFIELD, IL -- (Marketwired) -- 05/10/13 --
Horizon Pharma, Inc. (NASDAQ: HZNP) today provided an update on the Company's business and announced financial results for the first quarter ended March 31, 2013.
Financial Results
Gross and net sales for the first quarter of 2013 were $10.7 million and $9.2 million, respectively, increases of 70% and 73%, respectively, versus the fourth quarter of 2012, excluding the benefit of a one-time change in the timing of DUEXIS revenue recognition in the fourth quarter of 2012.
Net loss for t...
Read more »
Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 10, 2013
DEERFIELD, IL. - April 29, 2013 - Horizon Pharma, Inc. (Nasdaq: HZNP) announced today that its first quarter 2013 financial results will be released on Friday, May 10, 2013. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update.
The live webcast and a replay may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. Please connect to the Company's we...
Read more »
Horizon Pharma to Present at the 20th Annual Future Leaders in the Biotech Industry Conference
DEERFIELD, IL -- (Marketwire) -- 03/28/13 --
Horizon Pharma, Inc. (NASDAQ: HZNP), today announced that Timothy P. Walbert, chairman, president and chief executive officer will present at the 20th Annual Future Leaders in the Biotech Industry Conference on Friday, April 5th at 1:30p.m. Eastern Time in New York, NY. Mr. Walbert will provide an overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days...
Read more »
Horizon Pharma Reports 2012 Financial Results and Provides Business Update
DEERFIELD, IL -- (Marketwire) -- 03/18/13 --
Horizon Pharma, Inc. (NASDAQ: HZNP) today provided an update on the Company's business and announced financial results for the fourth quarter and year ended December 31, 2012.
Financial Highlights
Full year 2012 gross and net sales were $23.0 million and $19.6 million, respectively; increases of 231% and 183%, respectively, over full year 2011 gross and net sales.
Fourth quarter 2012 gross and net sales were $8.2 million and $6.7 million, respectively; increases of 130% and 91%, respectively, over fourth quarter...
Read more »
Horizon Pharma to Present at the 25th Annual ROTH Conference
DEERFIELD, IL -- (Marketwire) -- 03/11/13 --
Horizon Pharma, Inc. (NASDAQ: HZNP), today announced that Timothy P. Walbert, chairman, president and chief executive officer will present at the 25th Annual ROTH Conference on Monday, March 18th at 8:30a.m. Pacific Time in Laguna Nigel, CA. Mr. Walbert will provide an overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.
About Horizo...
Read more »